Literature DB >> 27154294

Regulatory roles of mast cells in immune responses.

Hideaki Morita1,2, Hirohisa Saito1, Kenji Matsumoto1, Susumu Nakae3,4.   

Abstract

Mast cells are important immune cells for host defense through activation of innate immunity (via toll-like receptors or complement receptors) and acquired immunity (via FcεRI). Conversely, mast cells also act as effector cells that exacerbate development of allergic or autoimmune disorders. Yet, several lines of evidence show that mast cells act as regulatory cells to suppress certain inflammatory diseases. Here, we review the mechanisms by which mast cells suppress diseases.

Entities:  

Keywords:  Contact hypersensitivity; Graft-versus-host disease; Innate-type allergic airway inflammation; Mast cell; Rejection

Mesh：

Substances：

Year:  2016        PMID： 27154294     DOI： 10.1007/s00281-016-0566-0

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN： 1863-2297            Impact factor:   9.623


  57 in total

1.  IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo.

Authors:  M Hara; C I Kingsley; M Niimi; S Read; S E Turvey; A R Bushell; P J Morris; F Powrie; K J Wood
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

2.  Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9).

Authors:  L Hültner; C Druez; J Moeller; C Uyttenhove; E Schmitt; E Rüde; P Dörmer; J Van Snick
Journal:  Eur J Immunol       Date:  1990-06       Impact factor: 5.532

3.  Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens.

Authors:  Anne Dudeck; Jan Dudeck; Julia Scholten; Anke Petzold; Sangeetha Surianarayanan; Anja Köhler; Katrin Peschke; David Vöhringer; Claudia Waskow; Thomas Krieg; Werner Müller; Ari Waisman; Karin Hartmann; Matthias Gunzer; Axel Roers
Journal:  Immunity       Date:  2011-06-24       Impact factor: 31.745

4.  Mast cells are essential intermediaries in regulatory T-cell tolerance.

Authors:  Li-Fan Lu; Evan F Lind; David C Gondek; Kathy A Bennett; Michael W Gleeson; Karina Pino-Lagos; Zachary A Scott; Anthony J Coyle; Jennifer L Reed; Jacques Van Snick; Terry B Strom; Xin Xiao Zheng; Randolph J Noelle
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

5.  IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development.

Authors:  J M Townsend; G P Fallon; J D Matthews; P Smith; E H Jolin; N A McKenzie
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

6.  Peptide analogs that inhibit IgE-Fc epsilon RI alpha interactions ameliorate the development of lethal graft-versus-host disease.

Authors:  R Korngold; B A Jameson; J M McDonnell; C Leighton; B J Sutton; H J Gould; G F Murphy
Journal:  Biol Blood Marrow Transplant       Date:  1997-10       Impact factor: 5.742

7.  An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor.

Authors:  Maho Suzukawa; Motoyasu Iikura; Rikiya Koketsu; Hiroyuki Nagase; Chise Tamura; Akiko Komiya; Susumu Nakae; Kouji Matsushima; Ken Ohta; Kazuhiko Yamamoto; Masao Yamaguchi
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

8.  IgE enhances parasite clearance and regulates mast cell responses in mice infected with Trichinella spiralis.

Authors:  Michael F Gurish; Paul J Bryce; Hong Tao; Alison B Kisselgof; Elizabeth M Thornton; Hugh R Miller; Daniel S Friend; Hans C Oettgen
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

Review 9.  Mouse models of graft-versus-host disease: advances and limitations.

Authors:  Mark A Schroeder; John F DiPersio
Journal:  Dis Model Mech       Date:  2011-05       Impact factor: 5.758

10.  Reevaluation of reserpine-induced suppression of contact sensitivity. Evidence that reserpine interferes with T lymphocyte function independently of an effect on mast cells.

Authors:  Y A Mekori; G L Weitzman; S J Galli
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307
View more
  11 in total

1.  Basophils and mast cells in immunity and inflammation.

Authors:  Yoshinori Yamanishi; Hajime Karasuyama
Journal:  Semin Immunopathol       Date:  2016-07-12       Impact factor: 9.623

Review 2.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

3.  Mast Cell Proteases Activate Astrocytes and Glia-Neurons and Release Interleukin-33 by Activating p38 and ERK1/2 MAPKs and NF-κB.

Authors:  Duraisamy Kempuraj; Ramasamy Thangavel; Gvindhasamy Pushpavathi Selvakumar; Mohammad Ejaz Ahmed; Smita Zaheer; Sudhanshu P Raikwar; Haris Zahoor; Daniyal Saeed; Iuliia Dubova; Gema Giler; Shelby Herr; Shankar S Iyer; Asgar Zaheer
Journal:  Mol Neurobiol       Date:  2018-06-18       Impact factor: 5.590

4.  MicroRNA-126 accelerates IgE-mediated mast cell degranulation associated with the PI3K/Akt signaling pathway by promoting Ca2+ influx.

Authors:  Yuan Bao; Song Wang; Yang Gao; Wen Zhang; Haitao Jin; Yang Yang; Jiangyu Li
Journal:  Exp Ther Med       Date:  2018-07-23       Impact factor: 2.447

Review 5.  Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration.

Authors:  Duraisamy Kempuraj; Ramasamy Thangavel; Govindhasamy P Selvakumar; Smita Zaheer; Mohammad E Ahmed; Sudhanshu P Raikwar; Haris Zahoor; Daniyal Saeed; Prashant A Natteru; Shankar Iyer; Asgar Zaheer
Journal:  Front Cell Neurosci       Date:  2017-07-24       Impact factor: 5.505

6.  Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity.

Authors:  Stefania Petrosino; Aniello Schiano Moriello; Roberta Verde; Marco Allarà; Roberta Imperatore; Alessia Ligresti; Ali Mokhtar Mahmoud; Alessio Filippo Peritore; Fabio Arturo Iannotti; Vincenzo Di Marzo
Journal:  J Neuroinflammation       Date:  2019-12-26       Impact factor: 8.322

7.  IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut.

Authors:  Giorgia Renga; Silvia Moretti; Vasilis Oikonomou; Monica Borghi; Teresa Zelante; Giuseppe Paolicelli; Claudio Costantini; Marco De Zuani; Valeria Rachela Villella; Valeria Raia; Rachele Del Sordo; Andrea Bartoli; Monia Baldoni; Jean-Christophe Renauld; Angelo Sidoni; Enrico Garaci; Luigi Maiuri; Carlo Pucillo; Luigina Romani
Journal:  Cell Rep       Date:  2018-05-08       Impact factor: 9.423

Review 8.  The role of extracellular vesicles when innate meets adaptive.

Authors:  Tom Groot Kormelink; Sanne Mol; Esther C de Jong; Marca H M Wauben
Journal:  Semin Immunopathol       Date:  2018-04-03       Impact factor: 9.623

Review 9.  MicroRNA Involvement in Allergic and Non-Allergic Mast Cell Activation.

Authors:  Irit Shefler; Pazit Salamon; Yoseph A Mekori
Journal:  Int J Mol Sci       Date:  2019-04-30       Impact factor: 5.923

10.  The lectin ArtinM activates RBL-2H3 mast cells without inducing degranulation.

Authors:  Patricia A A Buranello; Valéria C Barbosa-Lorenzi; Marcelo R Pinto; Gabriela Pereira-da-Silva; Maria Cristina R A Barreira; Maria Célia Jamur; Constance Oliver
Journal:  PLoS One       Date:  2020-03-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.